Triazolam

The evidence against is extensive and consistent [27]

A. Kales, Edward Bixler, Alexandros Vgontzas

Research output: Contribution to journalLetter

1 Citation (Scopus)
Original languageEnglish (US)
Pages (from-to)626
Number of pages1
JournalBritish Medical Journal
Volume307
Issue number6904
StatePublished - 1993

Fingerprint

Consumer Product Safety
Triazolam

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

@article{e5a2c1541c3a4de9bb279df91c2a740c,
title = "Triazolam: The evidence against is extensive and consistent [27]",
author = "A. Kales and Edward Bixler and Alexandros Vgontzas",
year = "1993",
language = "English (US)",
volume = "307",
pages = "626",
journal = "BMJ (Clinical research ed.)",
issn = "0267-0623",
publisher = "BMJ Publishing Group",
number = "6904",

}

Triazolam : The evidence against is extensive and consistent [27]. / Kales, A.; Bixler, Edward; Vgontzas, Alexandros.

In: British Medical Journal, Vol. 307, No. 6904, 1993, p. 626.

Research output: Contribution to journalLetter

TY - JOUR

T1 - Triazolam

T2 - The evidence against is extensive and consistent [27]

AU - Kales, A.

AU - Bixler, Edward

AU - Vgontzas, Alexandros

PY - 1993

Y1 - 1993

UR - http://www.scopus.com/inward/record.url?scp=0027320929&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027320929&partnerID=8YFLogxK

M3 - Letter

VL - 307

SP - 626

JO - BMJ (Clinical research ed.)

JF - BMJ (Clinical research ed.)

SN - 0267-0623

IS - 6904

ER -